Successful management of bupropion poisoning: possible benefit of acidosis treatment
Author(s) -
İsmail Altıntop,
Mehmet Tatlı
Publication year - 2017
Publication title -
the european research journal
Language(s) - English
Resource type - Journals
ISSN - 2149-3189
DOI - 10.18621/eurj.310619
Subject(s) - bupropion , medicine , antidepressant , anesthesia , metabolic acidosis , acidosis , smoking cessation , psychiatry , anxiety , pathology
Bupropion is used as an antidepressant and smoking cessation aid. It has been described in the literature as a norepinephrine - dopamine reuptake inhibitor and is also a nicotinic antagonist. Bupropion itself is not a common cause of intoxication cases seen in Emergency Department (ED). The most important side effect is an increase in risk for epileptic seizures. We aimed to present the management of a 29-year-old female patient in ED with epileptic seizures and acidosis due to bupropion intoxication,who had taken 30 bupropion 150 mg tablets and 16 fluoksetin 20 mg tablets for suicidal purpose. According to her blood gas counts sodium bicarbonate therapy was begun in ED and after having response to the treatment was continued in intensive care unit. She was discharged three days later without any other seizures and complications. Although bupropion intoxication is rare it can cause severe metabolic acidosis and epileptic seizures. There is no specific antidote therapy to bupropion so symptomatic therapy still have benefit.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom